ArticlePloS one2021

Beneficial impact of Ac3IV, an AVP analogue acting specifically at V1a and V1b receptors, on diabetes islet morphology and transdifferentiation of alpha- and beta-cells.

Shruti Mohan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.